Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: Retrospective analysis of 83 cases

Clinical Infectious Diseases

Volumn 22, Issue SUPPL. 2, 1996, Pages

  Dromer, Françoise ^a   Mathoulin, Simone ^b   Dupont, Bertrand ^b   Brugiere, Olivier ^b   Letenneur, Luc ^b  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CRYPTOCOCCOSIS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FUNGAL MENINGITIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030017169     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.supplement_2.s154     Document Type: Conference Paper

References (25)

1. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321: 794-9.
2. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991;91: 267-72.
3. Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and fluocytosine for four as compared with six weeks. N Engl J Med 1987;317: 334-41.
4. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974;80:176-81.
5. Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:533-8.
6. Sugar AM, Stem JJ, Dupont B. Overview: treatment of cryptococcal meningitis. Rev Infect Dis 1990;12(suppl 3):S338-48.
7. Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988;157:624-8.
8. Hay RJ, Mackenzie DWR, Campbell CK, Philpot CM. Cryptococcosis in the United Kingdom and the Irish Republic: an analysis of 69 cases. J Infect 1980;2:13-22.
9. Diamond RD. Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis. Infect Immun 1977;17: 187-94.
10. Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972;53:315-22.
11. Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989;149:2301-8.
12. Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann Intern Med 1990;113:183-7.
13. de Gans J, Portegies P, Tiessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-90.
14. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
15. Viviani MA, Tortorano AM, Giani PC, et al. Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome [letter]. Ann Intern Med 1987;106:166.
16. Tabone M-D, Leverger G, Landman J, Aznar C, Boccon-Gibod L, Lasfargues G. Disseminated lymphonodular cryptococcosis in a child with X-linked hyper-IgM immunodeficiency. Pediatr Infect Dis J 1994; 13:77-9.
17. White M, Cirrincione C, Belvins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 1992;165:960-3.
18. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994;19(suppl 1):S33-40.
19. Smith DK, Neal JJ, Holmberg SD, the Centers for Disease Control Idiopathic CD4+ T-Lymphocytopenia Task Force. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: an investigation of cases in the United States. N Engl J Med 1993;328: 373-9.
20. Eng RHK, Bishburg E, Smith SM, Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 1986;81:19-23.
21. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 1986;104:234-40.
22. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979;301:126-31.
23. Dismukes WE. Management of cryptococcosis. Clin Infect Dis 1993;17(suppl 2):S507-12.
24. Berry AJ, Rinaldi MG, Graybill JR. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob Agents Chemother 1992;36:690-2.
25. Haubrich RH, Haghighat D, Bozette SA, Tilles J, McCutchan JA, the Californian Collaborative Treatment Group. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J Infect Dis 1994;170:238-42.